ArticleScientific reports2025
Comparative analysis of three bronchopulmonary dysplasia diagnostic criteria in predicting longterm neurodevelopmental outcomes in preterm infants.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Ginkgolide B Alleviates Airway Inflammation in Hyperoxia Lung Injury.Immunity, inflammation and disease · 2026Article
- Optimal postnatal corticosteroid regimens to prevent bronchopulmonary dysplasia with minimal adverse effects.Clinical and experimental pediatrics · 2026Article
- Early prediction of bronchopulmonary dysplasia using new classification in high-risk preterm infants.Clinical and experimental pediatrics · 2026Article
- Endotracheal Intubation in Early Life and Its Association with Mental Health Disorders from Childhood to Adolescence: A National Longitudinal Cohort Study up to Age 18.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
This study compared the predictive value of three diagnostic criteria for bronchopulmonary dysplasia (BPD) in relation to death or neurodevelopmental impairment (NDI) at a corrected age of 24 months in preterm infants born before 32 weeks' gestation. In this retrospective cohort study conducted at a single center, 508 preterm infants with a median gestational age of 30.0 weeks were admitted between January 2019 and December 2021. BPD was diagnosed using the 2001 NICHD, 2018 NICHD, and 2019 Jensen definitions. Multivariate logistic regression and receiver operating characteristic (ROC) curve analysis were used to assess the predictive value of each definition. Of the infants, 52 (10.2%) experienced death or NDI. Severe BPD defined by the 2018 NICHD and 2019 Jensen criteria, and the presence of periventricular leukomalacia (PVL), were significant risk factors for adverse outcomes. Both the 2018 NICHD and 2019 Jensen definitions demonstrated superior predictive value compared to the 2001 NICHD definition. Combining these criteria with PVL further improved prediction efficiency. These findings suggest that newer BPD definitions, especially when combined with neuroimaging indicators, enhance prognostic accuracy for long-term neurodevelopmental outcomes in preterm infants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.